NXTC
NextCure Inc
NASDAQ: NXTC · HEALTHCARE · BIOTECHNOLOGY
$9.21
+3.02% today
Updated 2026-04-30
Market cap
$34.70M
P/E ratio
—
P/S ratio
9.52x
EPS (TTM)
$-19.65
Dividend yield
—
52W range
$4 – $16
Volume
0.1M
NextCure Inc (NXTC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |